Daphné Truan

Title: Daphné Truan: Innovator in HIV Research

Introduction

Daphné Truan is a notable inventor based in Haarlem, Netherlands. She has made significant contributions to the field of HIV research, particularly in the development of envelope proteins that stabilize the trimeric form of the virus. With a total of 6 patents to her name, her work is paving the way for advancements in vaccine development.

Latest Patents

Among her latest patents, Daphné Truan has developed innovative HIV envelope proteins that feature mutations designed to stabilize their trimeric form. These proteins exhibit an improved percentage of trimer formation and yield compared to traditional HIV envelope proteins. Additionally, her patents include nucleic acid molecules and vectors that encode these proteins, as well as compositions that incorporate the HIV envelope proteins, nucleic acids, and vectors.

Career Highlights

Daphné Truan is currently employed at Janssen Vaccines & Prevention B.V., where she continues her groundbreaking research. Her work focuses on enhancing the efficacy of HIV vaccines through the stabilization of envelope proteins. This innovative approach is crucial for developing effective treatments and preventive measures against HIV.

Collaborations

Throughout her career, Daphné has collaborated with esteemed colleagues, including Johannes Petrus Maria Langedijk and Lucy Rutten. These partnerships have fostered a collaborative environment that enhances the research and development of HIV-related innovations.

Conclusion

Daphné Truan's contributions to HIV research and her innovative patents are vital in the ongoing fight against the virus. Her work exemplifies the importance of scientific innovation in addressing global health challenges.